???global.info.a_carregar???
Identificação

Identificação pessoal

Nome completo
Paulo Jorge Costa Luz

Nomes de citação

  • Luz, Paulo

Identificadores de autor

Ciência ID
0913-A097-A3EE
ORCID iD
0000-0002-3905-0238
Formação
Grau Classificação
2018 - 2022
Em curso
 Ciências da Saúde (Doutoramento)
Universidade Lusófona de Humanidades e Tecnologias Centro de Investigação em Biociências e Tecnologias da Saúde, Portugal
2009 - 2015
Concluído
 Medicine (Mestrado integrado)
Universidad de Cádiz, Espanha
Percurso profissional

Ciência

Categoria Profissional
Instituição de acolhimento 		Empregador
2022 - Atual Investigador (Investigação) Savana Research, Espanha

Outras Carreiras

Categoria Profissional
Instituição de acolhimento 		Empregador
2022 - Atual Assistente (Médica) Centro Hospitalar Universitário do Algarve, Portugal
Produções

Publicações

Artigo em revista
  1. Inês Soares de Pinho; Paulo Luz; Lucy Alves; Raquel Lopes-Brás; Vanessa Patel; Miguel Esperança-Martins; Lisa Gonçalves; et al. "Anthracyclines versus No Anthracyclines in the Neoadjuvant Strategy for HER2+ Breast Cancer: Real-World Evidence". Clinical Drug Investigation (2023): https://doi.org/10.1007/s40261-023-01291-6.
    10.1007/s40261-023-01291-6
  2. Paulo Luz; Isabel Fernandes; Joana Magalhães; Rita Teixeira de Sousa; Pedro Faísca; João G. Costa; Ana S. Fernandes. "Tumor-infiltrating lymphocytes in early breast cancer: an exploratory analysis focused on HER2+ subtype in Portuguese patients". Current Medical Research and Opinion (2022): https://doi.org/10.1080/03007995.2022.2096334.
    10.1080/03007995.2022.2096334
  3. Gameiro-Santos, R.; Fernandes, I.G.; Luz, P.. "Prognostication in Metastatic Solid Tumours: Medical Community General Knowledge". BMJ Supportive and Palliative Care (2022): http://www.scopus.com/inward/record.url?eid=2-s2.0-85127683583&partnerID=MN8TOARS.
    10.1136/spcare-2022-003577
  4. Luz, Paulo. "Immunotherapy in Metastatic Mucosal Melanoma with Disseminated Intravascular Coagulation: A Case of Success". Case Reports in Immunology 2021 (2021): 1-5. http://dx.doi.org/10.1155/2021/5516004.
    10.1155/2021/5516004
  5. Luz, Paulo. "SURVIVAL COMPARISON OF HER2 METASTATIC BREAST CANCER PATIENTS ACCORDING TO HORMONE RECEPTOR STATUS: PORTUGUESE MULTICENTER EXPERIENCE". The Breast 59 (2021): S51-S51. http://dx.doi.org/10.1016/s0960-9776(21)00552-x.
    10.1016/s0960-9776(21)00552-x
  6. Luz, Paulo. "The evaluation of tumor-infiltrating lymphocytes (TILs) in early breast cancer: differences between histologic subtypes in a Portuguese cohort". The Breast 56 (2021): S63-S63. http://dx.doi.org/10.1016/s0960-9776(21)00202-2.
    10.1016/s0960-9776(21)00202-2
  7. Luz, Paulo. "Post neoadjuvant HER2 treatment: real world data from a multicentric cohort". The Breast 56 (2021): S22-S22. http://dx.doi.org/10.1016/s0960-9776(21)00099-0.
    10.1016/s0960-9776(21)00099-0
  8. Paulo Luz; Elsa Campoa; Rita Gameiro; Marta Vaz; Isabel Fernandes; Joana Magalhães; Beatriz Gosalbez; et al. "Systemic treatment of HER2-positive breast cancer patients with brain metastases: current status and exploratory case study in a Portuguese cohort". Journal Biomedical and Biopharmaceutical Research 18 1 (2021): 1-14. https://doi.org/10.19277/bbr.18.1.253.
    10.19277/bbr.18.1.253
  9. Paulo Luz. "Results of ECOG-ACRIN E2108 Trial: Is This the End of Primary Surgery in Metastatic Breast Cancer?". European Journal of Breast Health (2021): https://doi.org/10.4274/ejbh.2020.6222.
    10.4274/ejbh.2020.6222
  10. Luz, P.; Nobre Carvalho, A.; Oliveira, A.; Menezes, M.; Dinis, R.; Gosalbez, B.. "Prevalence of fear of death among young breast cancer patients during adjuvant endocrine therapy: Results from a Portuguese Cohort,Prevalência do medo de morrer em doentes jovens com cancro de mama durante a hormonoterapia adjuvante: Resultados de uma Coorte Portuguesa". Acta Medica Portuguesa 34 5 (2021): 400-401. http://www.scopus.com/inward/record.url?eid=2-s2.0-85105458949&partnerID=MN8TOARS.
    10.20344/amp.15201
  11. El Bairi, K.; Haynes, H.R.; Blackley, E.; Fineberg, S.; Shear, J.; Turner, S.; de Freitas, J.R.; et al. "The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group". npj Breast Cancer 7 1 (2021): http://www.scopus.com/inward/record.url?eid=2-s2.0-85120908291&partnerID=MN8TOARS.
    10.1038/s41523-021-00346-1
  12. Paulo Luz; David Dias; Ana Fortuna; Luis Bretes; Beatriz Gosalbez. "How shall we treat locally advanced triple negative breast cancer? [version 2; peer review: 2 approved]". (2020): https://f1000research.com/articles/8-1649/v2.
    10.12688/f1000research.20509.2
  13. Paulo Luz; Luis Bretes. "O Desafio de Tratar Doentes Oncológicos durante a Atual Pandemia Pela COVID19". Acta Médica Portuguesa 33 5 (2020): 354-354. https://doi.org/10.20344%2Famp.13766.
    10.20344/amp.13766
  14. Paulo Luz. "Osler Centenary Papers: Reflection on the use of antibiotics to treat ‘the old man’s friend’". Postgraduate Medical Journal 95 1130 (2019): 670-670. https://doi.org/10.1136/postgradmedj-2019-136823.
    10.1136/postgradmedj-2019-136823
  15. Paulo Luz. "Osler Centenary Papers: When the diagnosis is futile…". Postgraduate Medical Journal 95 1130 (2019): 669-669. https://doi.org/10.1136/postgradmedj-2019-136985.
    10.1136/postgradmedj-2019-136985
  16. Luz, Paulo. "EP277 Special considerations in quality of life of locally advanced cervical cancer patients". ePoster (2019): http://dx.doi.org/10.1136/ijgc-2019-esgo.338.
    10.1136/ijgc-2019-esgo.338
  17. Luz, Paulo. "EP276 Toxicity evaluation of locally advanced cervical cancer". ePoster (2019): http://dx.doi.org/10.1136/ijgc-2019-esgo.337.
    10.1136/ijgc-2019-esgo.337
  18. Luz, Paulo. "PRELIMINARY ANALYSIS OF TREATMENT DELAY WITH PALBOCICLIB ON PROGRESSION FREE SURVIVAL (PFS)". The Breast (2019): http://dx.doi.org/10.1016/s0960-9776(19)30705-2.
    10.1016/s0960-9776(19)30705-2
  19. Paulo Luz; David Dias; Ana Fortuna; Luis Bretes; Beatriz Gosalbez. "How shall we treat locally advanced triple negative breast cancer?". F1000Research 8 (2019): 1649-1649. https://doi.org/10.12688/f1000research.20509.1.
    10.12688/f1000research.20509.1
  20. Luz, Paulo. "Living longer and living better: breast cancer endocrine therapy". BMJ Supportive & Palliative Care (2019): http://dx.doi.org/10.1136/bmjspcare-2018-001666.
    10.1136/bmjspcare-2018-001666
  21. Luz, Paulo. "P-320Trifluridine/Tipiracil (TAS-102) in refractory metastatic colorectal cancer: Real-world data of 13 oncological centers in Portugal". Annals of Oncology (2019): http://dx.doi.org/10.1093/annonc/mdz155.319.
    10.1093/annonc/mdz155.319
  22. Luz, Paulo. "O Desafio de Tratar Idosos com Cancro". Acta Médica Portuguesa (2019): http://dx.doi.org/10.20344/amp.11965.
    10.20344/amp.11965
  23. Luz, Paulo. "BPI19-010: Febrile Neutropenia Induced by Chemotherapy: Impact of Risk Re-Stratification". Journal of the National Comprehensive Cancer Network (2019): http://dx.doi.org/10.6004/jnccn.2018.7207.
    10.6004/jnccn.2018.7207
  24. Luz, Paulo. "Adjuvant chemotherapy in young breast cancer patients with endrocrine receptor (ER) disease". The Breast (2018): http://dx.doi.org/10.1016/j.breast.2018.08.049.
    10.1016/j.breast.2018.08.049
  25. Luz, Paulo. "Breast cancer in young women: understanding our reality". The Breast (2018): http://dx.doi.org/10.1016/j.breast.2018.08.050.
    10.1016/j.breast.2018.08.050
  26. Luz, Paulo. "Impact of Molecular Subtypes in Patients with Metastatic Breast Cancer at Diagnosis". The Breast (2017): http://dx.doi.org/10.1016/s0960-9776(17)30730-0.
    10.1016/s0960-9776(17)30730-0
  27. Luz, Paulo. "Advanced Breast Cancer in Young Women: Outcome of a Portuguese Hospital". The Breast (2017): http://dx.doi.org/10.1016/s0960-9776(17)30715-4.
    10.1016/s0960-9776(17)30715-4